首页|三仁汤加减联合艾瑞昔布治疗急性痛风性关节炎临床观察

三仁汤加减联合艾瑞昔布治疗急性痛风性关节炎临床观察

扫码查看
目的 观察三仁汤加减联合艾瑞昔布治疗急性痛风性关节炎(湿热痹阻证)临床疗效及对实验室指标的影响.方法 将80例患者分为对照组与观察组各40例.对照组患者在常规治疗基础上给予艾瑞昔布片治疗,观察组在对照组治疗基础上联合三仁汤加减方治疗,均连续治疗7 d.观察两组患者治疗前后主要症状体征积分、湿热体质积分、血尿酸(UA)、血沉(ESR)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、白细胞介素-1 β(IL-1β)水平变化,比较两组治疗后临床疗效、湿热体质改善疗效,并评价两组治疗安全性情况.结果 两组治疗后关节急性红肿、关节压痛、关节疼痛及关节活动障碍度评分均降低(P<0.05),且观察组治疗后以上症状体征积分均低于对照组(P<0.05);两组治疗后身重困倦、口苦口干、心烦懈怠、大便黏滞或燥结、小便短赤积分均降低(P<0.05),且观察组均低于对照组(P<0.05);两组治疗后UA、ESR、CRP、TNF-α、IL-6、IL-1β水平均降低(P<0.05),且观察组均低于对照组(P<0.05);观察组总有效率为92.50%,明显高于对照组的75.00%(P<0.05);观察组湿热体质改善总有效率90.00%,明显高于对照组72.50%(P<0.05);两组治疗期间均未出现明显与用药相关的不良反应.结论 三仁汤加减联合艾瑞昔布治疗急性痛风性关节炎(湿热痹阻证)疗效显著,能够有效缓解患者临床症状,改善湿热体质,调节理化检查指标水平,且毒副作用小,可为痛风性关节炎急性发作的中西医治疗提供新的思路.
Clinical Observation of Modified Sanren Decoction Combined with Iricoxib in the Treatment of Acute Gouty Arthritis
Objective:To explore the clinical efficacy of Modified Sanren Decoction combined with irecoxib in the treatment of acute gouty arthritis with syndrome of heat-dampness blockage and its impact on laboratory indi-cators.Methods:A total of 80 patients were randomly divided into a control group and an observation group,with 40 cases each.The control group was treated with iricoxib tablets on the basis of routine treatment,while the obser-vation group was treated with Modified Sanren Decoction on the basis of the control group.All were continuously treated for 7 days.The main symptoms and signs of two groups before and after treatment,dampness and heat con-stitution score,laboratory indicators(UA,ESR,CRP),and serum inflammation indicators TNF-α,IL-6,IL-1β changes were observed;the clinical efficacy and improvement of heat-dampness constitution between the two groups after treatment were compared,and the safety of the two groups treatments was evaluated.Results:After treatment,the scores of acute joint redness and swelling,joint tenderness,joint pain,and joint mobility disorders in both groups were all decreased(P<0.05),and the scores of the above symptoms and signs in the observation group were lower than those in the control group(P<0.05);the scores of heavy body drowsiness,bitter and dry mouth,irritated and lax,sticky or dry stools,short and red urine in both groups were all decreased(P<0.05),and the observation group was lower than the control group(P<0.05).The levels of UA,ESR,CRP,TNF-α,IL-6,IL-1β in both groups were all decreased(P<0.05),and the observation group was lower than the control group(P<0.05).The total effective rate of 92.50%in the observation group was significantly higher than 75.00%in the control group(P<0.05);the total effective rate of improving heat-dampness constitution in the observation group was 90.00%,which was significantly higher than 72.50%in the control group(P<0.05).There were no significant adverse reactions related to medication during the treatment period in both groups.Conclusion:The treatment of acute gouty arthritis with Modified Sanren Decoction combined with iricoxib has a significant therapeutic effect on dampness heat blockage syndrome.It can effectively alleviate clinical symptoms,improve dampness heat constitu-tion,regulate physical and chemical examination index levels,and has minimal toxic and side effects.It can pro-vide a new approach for the treatment of acute gouty arthritis with traditional Chinese and western medicine.

Acute gouty arthritisSyndrome of heat-dampness blockageModified Sanren DecoctionHeat-dampness constitutionPhysical and chemical inspection indicatorsInflammatory indicators

张永刚、李慧艳、张绍君、严亚萍、王平、侯亚卓、杨宗娜、王一帆、李俊巧

展开 >

河北省保定市第一中心医院,河北保定 071000

急性痛风性关节炎 湿热痹阻证 三仁汤加减方 湿热体质 理化检查指标 炎症指标

河北省医学科学研究项目保定市科技计划

202202832341ZF106

2024

中国中医急症
中华中医药学会

中国中医急症

CSTPCD
影响因子:1.144
ISSN:1004-745X
年,卷(期):2024.33(3)
  • 22